These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 18032504)

  • 1. Mapping of equine lentivirus receptor 1 residues critical for equine infectious anemia virus envelope binding.
    Zhang B; Sun C; Jin S; Cascio M; Montelaro RC
    J Virol; 2008 Feb; 82(3):1204-13. PubMed ID: 18032504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of equine infectious anemia virus to the equine lentivirus receptor-1 is mediated by complex discontinuous sequences in the viral envelope gp90 protein.
    Sun C; Zhang B; Jin J; Montelaro RC
    J Gen Virol; 2008 Aug; 89(Pt 8):2011-2019. PubMed ID: 18632973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A tumor necrosis factor receptor family protein serves as a cellular receptor for the macrophage-tropic equine lentivirus.
    Zhang B; Jin S; Jin J; Li F; Montelaro RC
    Proc Natl Acad Sci U S A; 2005 Jul; 102(28):9918-23. PubMed ID: 15985554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural insight into equine lentivirus receptor 1.
    Qian L; Han X; Liu X
    Protein Sci; 2015 May; 24(5):633-42. PubMed ID: 25559821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An equine infectious anemia virus variant superinfects cells through novel receptor interactions.
    Brindley MA; Zhang B; Montelaro RC; Maury W
    J Virol; 2008 Oct; 82(19):9425-32. PubMed ID: 18667522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mice transgenic for equine cyclin T1 and ELR1 are susceptible to equine infectious anemia virus infection.
    Du C; Ma J; Liu Q; Li YF; He XJ; Lin YZ; Wang XF; Meng QW; Wang X; Zhou JH
    Retrovirology; 2015 Apr; 12():36. PubMed ID: 25928027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The soluble form of the EIAV receptor encoded by an alternative splicing variant inhibits EIAV infection of target cells.
    Lin YZ; Yang F; Zhang SQ; Sun LK; Wang XF; Du C; Zhou JH
    PLoS One; 2013; 8(11):e79299. PubMed ID: 24278125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonsynonymous changes of equine lentivirus receptor-1 (ELR1) gene in amino acids involved in the interaction with equine infectious anemia virus (EIAV).
    Corbi-Botto CM; Sadaba SA; Zappa ME; Peral-García P; Díaz S
    Res Vet Sci; 2017 Jun; 112():185-191. PubMed ID: 28500993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-based analysis of the herpes simplex virus glycoprotein D binding site present on herpesvirus entry mediator HveA (HVEM).
    Connolly SA; Landsburg DJ; Carfi A; Wiley DC; Eisenberg RJ; Cohen GH
    J Virol; 2002 Nov; 76(21):10894-904. PubMed ID: 12368332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Equine infectious anemia virus envelope evolution in vivo during persistent infection progressively increases resistance to in vitro serum antibody neutralization as a dominant phenotype.
    Howe L; Leroux C; Issel CJ; Montelaro RC
    J Virol; 2002 Nov; 76(21):10588-97. PubMed ID: 12368301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Establishment of a 293-cell line containing luciferase reporter for EIAV receptor and LTR functions].
    Wang DF; Zhang SQ; Ma XE; Jian ZJ; Zhou JH
    Wei Sheng Wu Xue Bao; 2007 Dec; 47(6):1070-5. PubMed ID: 18271266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Replication of equine infectious anemia virus in engineered mouse NIH 3T3 cells.
    Zhang B; Montelaro RC
    J Virol; 2009 Feb; 83(4):2034-7. PubMed ID: 19073738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-based mutagenesis of herpes simplex virus glycoprotein D defines three critical regions at the gD-HveA/HVEM binding interface.
    Connolly SA; Landsburg DJ; Carfi A; Wiley DC; Cohen GH; Eisenberg RJ
    J Virol; 2003 Jul; 77(14):8127-40. PubMed ID: 12829851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unique evolution characteristics of the envelope protein of EIAV(LN₄₀), a virulent strain of equine infectious anemia virus.
    Wang X; Wang S; Lin Y; Jiang C; Ma J; Zhao L; Lv X; Wang F; Shen R; Zhou J
    Virus Genes; 2011 Apr; 42(2):220-8. PubMed ID: 21369830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Localization of conserved and variable antigenic domains of equine infectious anemia virus envelope glycoproteins using recombinant env-encoded protein fragments produced in Escherichia coli.
    Payne SL; Rushlow K; Dhruva BR; Issel CJ; Montelaro RC
    Virology; 1989 Oct; 172(2):609-15. PubMed ID: 2552661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of herpes simplex virus gD and lymphotoxin-alpha binding to HveA by peptide antagonists.
    Sarrias MR; Whitbeck JC; Rooney I; Spruce L; Kay BK; Montgomery RI; Spear PG; Ware CF; Eisenberg RJ; Cohen GH; Lambris JD
    J Virol; 1999 Jul; 73(7):5681-7. PubMed ID: 10364318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localization of the gD-binding region of the human herpes simplex virus receptor, HveA.
    Whitbeck JC; Connolly SA; Willis SH; Hou W; Krummenacher C; Ponce de Leon M; Lou H; Baribaud I; Eisenberg RJ; Cohen GH
    J Virol; 2001 Jan; 75(1):171-80. PubMed ID: 11119586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variable regions A and B in the envelope glycoproteins of feline leukemia virus subgroup B and amphotropic murine leukemia virus interact with discrete receptor domains.
    Tailor CS; Kabat D
    J Virol; 1997 Dec; 71(12):9383-91. PubMed ID: 9371598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The three HveA receptor ligands, gD, LT-alpha and LIGHT bind to distinct sites on HveA.
    Sarrias MR; Whitbeck JC; Rooney I; Ware CF; Eisenberg RJ; Cohen GH; Lambris JD
    Mol Immunol; 2000 Aug; 37(11):665-73. PubMed ID: 11164894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epitope shifting of gp90-specific cellular immune responses in EIAV-infected ponies.
    Liu C; Cook SJ; Craigo JK; Cook FR; Issel CJ; Montelaro RC; Horohov DW
    Vet Immunol Immunopathol; 2014 Oct; 161(3-4):161-9. PubMed ID: 25176006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.